American Century Companies’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.99M | Buy |
136,200
+8,957
| +7% | +$86.4K | ﹤0.01% | 2198 |
|
|
2026
Q1 | $944K | Buy |
127,243
+55,954
| +78% | +$589K | ﹤0.01% | 2348 |
|
|
2025
Q4 | $838K | Buy |
71,289
+49,180
| +222% | +$531K | ﹤0.01% | 2376 |
|
|
2025
Q3 | $171K | Sell |
22,109
-3,495,369
| -99% | -$24.5M | ﹤0.01% | 2711 |
|
|
2025
Q2 | $25.7M | Buy |
3,517,478
+197,876
| +6% | +$1.6M | 0.01% | 968 |
|
|
2025
Q1 | $31.5M | Buy |
3,319,602
+426,341
| +15% | +$5.32M | 0.02% | 825 |
|
|
2024
Q4 | $47.7M | Sell |
2,893,261
-132,683
| -4% | -$2.06M | 0.03% | 657 |
|
|
2024
Q3 | $44.6M | Sell |
3,025,944
-235,812
| -7% | -$3.69M | 0.03% | 650 |
|
|
2024
Q2 | $45.2M | Buy |
3,261,756
+167,145
| +5% | +$2.37M | 0.03% | 615 |
|
|
2024
Q1 | $48.6M | Buy |
3,094,611
+1,103,919
| +55% | +$17M | 0.03% | 564 |
|
|
2023
Q4 | $32.2M | Buy |
1,990,692
+1,963,810
| +7,305% | +$32.1M | 0.02% | 681 |
|
|
2023
Q3 | $331K | Sell |
26,882
-40,211
| -60% | -$598K | ﹤0.01% | 2426 |
|
|
2023
Q2 | $1.08M | Buy |
67,093
+20,408
| +44% | +$336K | ﹤0.01% | 1905 |
|
|
2023
Q1 | $798K | Buy |
46,685
+15,079
| +48% | +$215K | ﹤0.01% | 1959 |
|
|
2022
Q4 | $292K | Buy |
+31,606
| New | +$295K | ﹤0.01% | 2223 |
|
|
2022
Q2 | – | Sell |
-370,783
| Closed | -$4.5M | – | 2366 |
|
|
2022
Q1 | $4.5M | Sell |
370,783
-204,557
| -36% | -$4.3M | ﹤0.01% | 1135 |
|
|
2021
Q4 | $19.6M | Sell |
575,340
-41,313
| -7% | -$1.62M | 0.01% | 704 |
|
|
2021
Q3 | $29.7M | Buy |
616,653
+64,886
| +12% | +$3M | 0.02% | 585 |
|
|
2021
Q2 | $24.9M | Sell |
551,767
-2,253
| -0.4% | -$99.8K | 0.02% | 624 |
|
|
2021
Q1 | $26.7M | Sell |
554,020
-134,906
| -20% | -$7.02M | 0.02% | 583 |
|
|
2020
Q4 | $37.1M | Buy |
688,926
+80,487
| +13% | +$3.64M | 0.03% | 462 |
|
|
2020
Q3 | $22.4M | Sell |
608,439
-66,080
| -10% | -$2.46M | 0.02% | 514 |
|
|
2020
Q2 | $20.9M | Buy |
674,519
+165,912
| +33% | +$4.6M | 0.02% | 503 |
|
|
2020
Q1 | $14M | Buy |
508,607
+25,716
| +5% | +$770K | 0.02% | 524 |
|
|
2019
Q4 | $14.1M | Buy |
482,891
+65,059
| +16% | +$1.55M | 0.01% | 601 |
|
|
2019
Q3 | $7.99M | Sell |
417,832
-270,791
| -39% | -$6.35M | 0.01% | 663 |
|
|
2019
Q2 | $15.1M | Buy |
688,623
+49,977
| +8% | +$1.1M | 0.02% | 553 |
|
|
2019
Q1 | $13.1M | Sell |
638,646
-49,129
| -7% | -$854K | 0.01% | 560 |
|
|
2018
Q4 | $8.67M | Buy |
687,775
+380,041
| +123% | +$5.66M | 0.01% | 638 |
|
|
2018
Q3 | $4.72M | Buy |
+307,734
| New | +$4.25M | ﹤0.01% | 868 |
|
Other funds holding NEO
FLAM
GF
NAMI
B
American Century Companies's NEO Position: Q2 2026 in Review
American Century Companies increased its NeoGenomics (NEO) stake by 7% in Q2 2026, buying an estimated $86.4K and bringing the position to 136,200 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #2198.
American Century Companies first reported a position in NEO in Q3 2018 and has held it in 30 quarters since. The position peaked at $48.6M in Q1 2024. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- American Century Companies held 136,200 shares of NeoGenomics worth $1.99M as of Q2 2026.
- American Century Companies bought 8,957 NeoGenomics shares in Q2 2026, an estimated $86.4K.
- NeoGenomics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2198 holding.
- American Century Companies first reported a position in NeoGenomics in Q3 2018 and has held it in 30 quarters since.
- American Century Companies's NeoGenomics position peaked at $48.6M in Q1 2024.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.